DYRK1A and ovarian carcinoma: Notably, DYRK1A-mediated DREAM complex formation was proposed to be responsible for ovarian cancer cell dormancy [79] and for the quiescence of gastrointestinal stromal tumor (GIST) cells induced by treatment with imatinib [80].